Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vesicular nucleotide transporter (VNUT) is a membrane protein (SLC17A9) responsible for the active transport and storage of nucleotides, primarily ATP, into secretory vesicles. Upon stimulation, these vesicles release ATP, enabling purinergic signaling. VNUT plays roles in pain perception, inflammation, and other physiological processes, making it a potential therapeutic target. Inhibitors like clodronate and EPA metabolites can modulate its activity.
Inhibition of vesicular nucleotide transport, reducing ATP release and purinergic signaling
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vesicular Nucleotide Transporter (VNUT).